Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease

被引:888
作者
Lange, Peter [1 ,2 ,3 ]
Celli, Bartolome [6 ]
Agusti, Alvar [7 ,9 ]
Jensen, Gorm Boje [3 ,5 ]
Divo, Miguel [6 ]
Faner, Rosa [8 ,9 ]
Guerra, Stefano [11 ]
Marott, Jacob Louis [3 ]
Martinez, Fernando D. [11 ]
Martinez-Camblor, Pablo [12 ]
Meek, Paula [13 ]
Owen, Caroline A. [6 ]
Petersen, Hans [14 ]
Pinto-Plata, Victor [6 ]
Schnohr, Peter [3 ]
Sood, Akshay [15 ]
Soriano, Joan B. [10 ]
Tesfaigzi, Yohannes [14 ]
Vestbo, Jorgen [4 ,16 ]
机构
[1] Univ Copenhagen, Inst Publ Hlth, Sect Social Med, DK-1014 Copenhagen K, Denmark
[2] Univ Copenhagen, Resp Sect, Hvidovre Hosp, DK-1014 Copenhagen K, Denmark
[3] Univ Copenhagen, Copenhagen City Heart Study, Frederiksberg Hosp, DK-1014 Copenhagen K, Denmark
[4] Univ Copenhagen, Dept Resp Med, Gentofte Hosp, DK-1014 Copenhagen K, Denmark
[5] Univ Southern Denmark, Odense, Denmark
[6] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[7] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Hosp Clin, Serv Pneumol,Thorax Inst, Barcelona, Spain
[8] Fundacio Clin Recerca Biomed, Barcelona, Spain
[9] Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain
[10] Univ Autonoma Madrid, Catedra UAM Linde, Inst Invest Hosp Univ Princesa, Madrid, Spain
[11] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA
[12] Univ Autonoma Chile, Santiago, Chile
[13] Univ Colorado, Denver, CO 80202 USA
[14] Lovelace Resp Res Inst, Albuquerque, NM USA
[15] Univ New Mexico, Albuquerque, NM 87131 USA
[16] Univ Manchester, Manchester Acad Hlth Sci Ctr, Resp & Allergy Res Grp, Manchester, Lancs, England
关键词
FORCED EXPIRATORY VOLUME; FUNCTION DECLINE; NATURAL-HISTORY; INHALED BUDESONIDE; CHILDHOOD ASTHMA; PROGRESSION; REGRESSION; MODERATE; SMOKERS; FACTS;
D O I
10.1056/NEJMoa1411532
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Chronic obstructive pulmonary disease (COPD) is thought to result from an accelerated decline in forced expiratory volume in 1 second (FEV1) over time. Yet it is possible that a normal decline in FEV1 could also lead to COPD in persons whose maximally attained FEV1 is less than population norms. METHODS We stratified participants in three independent cohorts (the Framingham Offspring Cohort, the Copenhagen City Heart Study, and the Lovelace Smokers Cohort) according to lung function (FEV1 >= 80% or <80% of the predicted value) at cohort inception (mean age of patients, approximately 40 years) and the presence or absence of COPD at the last study visit. We then determined the rate of decline in FEV1 over time among the participants according to their FEV1 at cohort inception and COPD status at study end. RESULTS Among 657 persons who had an FEV1 of less than 80% of the predicted value before 40 years of age, 174 (26%) had COPD after 22 years of observation, whereas among 2207 persons who had a baseline FEV1 of at least 80% of the predicted value before 40 years of age, 158 (7%) had COPD after 22 years of observation (P<0.001). Approximately half the 332 persons with COPD at the end of the observation period had had a normal FEV1 before 40 years of age and had a rapid decline in FEV1 thereafter, with a mean (+/- SD) decline of 53 +/- 21 ml per year. The remaining half had had a low FEV1 in early adulthood and a subsequent mean decline in FEV1 of 27 +/- 18 ml per year (P<0.001), despite similar smoking exposure. CONCLUSIONS Our study suggests that low FEV1 in early adulthood is important in the genesis of COPD and that accelerated decline in FEV1 is not an obligate feature of COPD. (Funded by an unrestricted grant from GlaxoSmithKline and others.)
引用
收藏
页码:111 / 122
页数:12
相关论文
共 50 条
  • [31] Lung function and symptom recovery in chronic obstructive pulmonary disease with pneumonic and non-pneumonic exacerbations
    Nunn, Matthew
    Parker, Jennie
    Leduc, Jean-Gregoire
    Wigerius, Denise
    Matheson, Kara
    Hernandez, Paul
    [J]. CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2024, 8 (04) : 150 - 158
  • [32] Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease
    Agusti, Alvar
    Hogg, James C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13) : 1248 - 1256
  • [33] New Perspectives on Chronic Obstructive Pulmonary Disease
    Celli, Bartolome R.
    Singh, Dave
    Vogelmeier, Claus
    Agusti, Alvar
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 2127 - 2136
  • [34] Chronic obstructive pulmonary disease
    Vijayan, V. K.
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2013, 137 : 251 - 269
  • [35] Cholinergic Hyperresponsiveness of Peripheral Lung Parenchyma in Chronic Obstructive Pulmonary Disease
    Lancas, Tatiana
    Kasahara, David Itiro
    Gross, Jefferson Luiz
    Pires-Neto, Ruy Camargo
    Deheinzelin, Daniel
    Mauad, Thais
    Negri, Elnara Marcia
    Dolhnikoff, Marisa
    [J]. RESPIRATION, 2011, 82 (02) : 177 - 184
  • [36] Pulmonary MicroRNA Changes Alter Angiogenesis in Chronic Obstructive Pulmonary Disease and Lung Cancer
    Green, Clara E.
    Clarke, Joseph
    Bicknell, Roy
    Turner, Alice M.
    [J]. BIOMEDICINES, 2021, 9 (07)
  • [37] Chronic Obstructive Pulmonary Disease 1 New insights into the immunology of chronic obstructive pulmonary disease
    Brusselle, Guy G.
    Joos, Guy F.
    Bracke, Ken R.
    [J]. LANCET, 2011, 378 (9795) : 1015 - 1026
  • [38] Quantitative assessment of pulmonary vascular alterations in chronic obstructive lung disease: Associations with pulmonary function test and survival in the KOLD cohort
    Cho, Young Hoon
    Lee, Sang Min
    Seo, Joon Beom
    Kim, Namkug
    Bae, Jang Pyo
    Lee, Jae Seung
    Oh, Yeon-Mok
    Do-Lee, Sang
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2018, 108 : 276 - 282
  • [39] Tensin1 expression and function in chronic obstructive pulmonary disease
    Stylianou, Panayiota
    Clark, Katherine
    Gooptu, Bibek
    Smallwood, Dawn
    Brightling, Christopher E.
    Amrani, Yassine
    Roach, Katy M.
    Bradding, Peter
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [40] Reduced ambient PM2.5, better lung function, and decreased risk of chronic obstructive pulmonary disease
    Bo, Yacong
    Chang, Ly-yun
    Guo, Cui
    Lin, Changqing
    Lau, Alexis K. H.
    Tam, Tony
    Lao, Xiang Qian
    [J]. ENVIRONMENT INTERNATIONAL, 2021, 156